Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience - Test2 - elhamkhani - TriplyDB

Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience

Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience

http://www.wikidata.org/entity/Q33845768

about

2012 Update in addiction medicine for the generalist Mental health collaborative care and its role in primary care settings Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically.A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry Emerging adult age status predicts poor buprenorphine treatment retention.Buprenorphine Treatment for Probationers and Parolees.Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers Consultation psychiatry in the medical home and accountable care organizations: achieving the triple aim.Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.A Multicomponent Intervention to Improve Primary Care Provider Adherence to Chronic Opioid Therapy Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled Trial Protocol.Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine.Long-term retention in Office Based Opioid Treatment with buprenorphine.Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.A Hepatitis C Treatment Program Based in a Safety-Net Hospital Patient-Centered Medical Home.Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.Introduction to the Special Issue on the Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and/or Drug Use Interventions and Medical Care.Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes.Initiation of buprenorphine during incarceration and retention in treatment upon release.Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes.Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.Integration of substance use disorder services with primary care: health center surveys and qualitative interviews.Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.What is integrated care?Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial.Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration.Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment.Association between process measures and mortality in individuals with opioid use disorders.

P2860

Q26864774-DDF704B7-D13A-47C6-B906-73F64CC300C6 Q26999874-E97437C3-7E5D-4385-BF0C-D259CE9847DA Q28265279-EDDB0E5B-0100-4EBF-95D0-3773015DC62B Q33859272-12666C31-6C84-440B-95DA-C114ACBE76D9 Q34030894-A4953EDF-03E8-4190-B8AF-AE4287324354 Q34269194-A2FBD804-94EB-4A6F-8EE8-D89B36339E08 Q34289480-D904F6C8-0F77-4317-A0C9-A7BAED7306B5 Q35112836-B4C98346-E745-437D-A495-C83D6F567148 Q35120048-C50EBFCC-8DE1-4F08-ADDD-55A30EFF6CB8 Q35733318-5041DC53-30D0-4BA1-B589-21E0AFBC094D Q35740890-62C7650B-A026-4F6E-89FF-291D68B3033F Q35961748-B0037264-A5B8-4B39-A72E-99CAFFAE4CBD Q35980664-153289AB-8FBD-4EFB-928A-2AD52BF2BB80 Q36030969-FA38B5F0-30BF-4B8B-9917-31B5C649E7F9 Q36080932-FEBFA876-3CC5-484A-940D-ED683BAAFFA8 Q36198525-37FFE529-A5B0-496E-BB4D-C3CF3CADB54D Q36249927-8E930391-44B4-4732-ACC5-1B988CC04D21 Q36253355-ED9107C2-350C-4DD0-BF54-71BE544319B3 Q36263379-A83F456C-8C1E-4E17-A639-72C8919B5E52 Q36277232-AE8E7431-3DFE-450A-9CE4-34262DA8397E Q36315633-61B49B1D-CB09-4465-BCF5-7B8D7A473634 Q36366464-88E3F819-4D6D-4938-BEF8-18747373B41E Q36476423-5DE37B90-53E1-4E49-B460-6E28D376C307 Q36554145-DCD57607-A2E2-449C-BB1E-EAA51030E71A Q36738043-B3CB125C-0873-48AC-A95E-1DD43C2D3C3E Q36821137-8910CC36-8EC5-4ECB-823E-2AC133F1E76F Q36906548-34A65C6E-5CF9-459A-94DC-F90EB87FF027 Q36948204-AF9845D5-2159-4319-8EBD-51B86EABA34D Q36960916-617CE7BC-D97B-4EC7-BDF9-9C0BA475ED71 Q37079839-6EEB9B7B-F7DF-44C0-BD7F-3C7B47E0954F Q37565076-6E5ABA21-D21F-4C19-8906-8DD8FAF847F8 Q37673456-C71F83D2-53D5-42F7-85CD-3C760DB086AA Q37689314-77059EB1-51C3-4711-99EF-AF1A133F21AC Q38244651-E15F3D69-0408-477C-9F8D-1303B33168CE Q38305584-FF33111B-04D3-4C11-A79C-0B283A3A233D Q38373836-6D2BE950-CCB4-40D0-9037-5880902D5F43 Q38687655-B2B0164A-3859-4901-BF45-369C3E70738F Q38695672-828358AB-1C76-4CC6-A947-34D569EB1242 Q38695676-3AF5B168-5561-4500-B654-235D95E67DA9 Q38701857-CF9A6A45-7703-4985-9C3D-8BE68BCEAD5F

P2860

Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience

http://www.wikidata.org/entity/Q33845768

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Collaborative care of opioid-a ...... norphine: five-year experience

@ast

Collaborative care of opioid-a ...... norphine: five-year experience

@en

type

label

Collaborative care of opioid-a ...... norphine: five-year experience

@ast

Collaborative care of opioid-a ...... norphine: five-year experience

@en

prefLabel

Collaborative care of opioid-a ...... norphine: five-year experience

@ast

Collaborative care of opioid-a ...... norphine: five-year experience

@en

P1433

Q33845768-44090A62-0C5D-4C0B-8030-DD96910741B1

P1476

Q33845768-6A57D6C0-DB77-4C57-A556-D21A6B9D7A95

P2093

Q33845768-0476A5A0-8339-4DAD-B9C3-81F05E7549E8

Q33845768-32C2BA60-628C-4103-A40E-6FD3A21FBDB6

Q33845768-4082B162-E7DC-4707-82D4-F95784FB5A6A

Q33845768-53FC4604-4E94-4F71-B315-FB34EDCC7AA6

Q33845768-DB01D9AF-1292-45D7-8F5A-7014C1BE8D06

P2860

Q33845768-0A09B39B-7E5E-4B16-BC0D-27318C14BD24

Q33845768-1485CB67-BEC2-4B10-BED7-5560A03D178A

Q33845768-218657C4-1963-43FE-822D-4DDBAD27B2E2

Q33845768-2AEC01B0-46D9-4E5F-A87A-0831D7C214FA

Q33845768-38DB5375-8737-4881-9674-D41C7CE3BB38

Q33845768-3B8532BC-A3D4-49FA-BA1A-D720038FCB8B

Q33845768-4464A1DA-F232-4157-B1C1-58EC6C10DA0B

Q33845768-4C4595F6-E133-410D-822C-C11D664D571E

Q33845768-5347DA38-98BA-4C70-95D5-ED2924861C02

Q33845768-65FB42B7-0C6C-42FB-B95C-88D6A0133350

P304

Q33845768-D0764A07-89B6-4D66-87C0-497538B15A63

P31

Q33845768-8261125E-3606-4787-B6B8-0DA9B4DFED13

P356

Q33845768-14BE6238-E6A5-4EBF-A03D-ABC47C9F56D1

P407

Q33845768-5584CB45-DE38-4F09-A6E0-3E95B68AAA08

P433

Q33845768-38E8C2C2-B4AF-4E67-989E-219B2E3846C8

P478

Q33845768-70173CB1-048F-48A9-98D6-9C0841C99E04

P50

Q33845768-285212A7-352E-4EC7-9991-4E3770A371B5

Q33845768-8B11C8F7-9CF1-4FB8-895B-E91924CA3EFA

P577

Q33845768-09AB8C7D-846A-4EC6-A662-C146A80F63D9

P5875

Q33845768-6C020D87-BE48-48E8-A83C-9F8E4B9E6BFD

P698

Q33845768-9D1A7B20-00A9-4802-9147-AB8912B7ABB7

P921

Q33845768-3BDD497D-FC6C-4E07-B7AE-833C309E092D

Q33845768-bbc3d7c7-a16c-493c-84e6-4ce91281698a

P932

Q33845768-61E8C187-00D0-4AAF-8791-A759253846A3

P356

ARCHINTERNMED.2010.541

P1433

JAMA Internal Medicine

P1476

Collaborative care of opioid-a ...... norphine: five-year experience

@en

P2093

Alexis Bergeron

http://www.w3.org/2001/XMLSchema#string

Colleen T LaBelle

http://www.w3.org/2001/XMLSchema#string

Michael Botticelli

http://www.w3.org/2001/XMLSchema#string

Michael Winter

http://www.w3.org/2001/XMLSchema#string

Natalie Kretsch

http://www.w3.org/2001/XMLSchema#string

P2860

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

Buprenorphine treatment in an urban community health center: what to expect

Science-based views of drug addiction and its treatment.

Home- versus office-based buprenorphine inductions for opioid-dependent patients.

Factors affecting willingness to provide buprenorphine treatment.

Integrating buprenorphine treatment into office-based practice: a qualitative study

Buprenorphine retention in primary care.

Clinical practice. Office-based treatment of opioid-dependent patients.

Treating homeless opioid dependent patients with buprenorphine in an office-based setting.

P304

425-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2010.541

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Daniel P Alford

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50395210

http://www.w3.org/2001/XMLSchema#string

P698

21403039

http://www.w3.org/2001/XMLSchema#string

P921

P932

3059544

http://www.w3.org/2001/XMLSchema#string